| Bladder Urothelial Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived47 of 47show fewer |
|---|
| → investigated in trials for | Gemcitabinesmall molecule 21 trials (14 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 20 trials (14 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 16 trials (12 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 9 trials (8 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 7 trials (7 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nadofaragene Firadenovecgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tovorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |